Literature DB >> 15657472

Gastrointestinal discomfort during intermittent high-intensity exercise: effect of carbohydrate-electrolyte beverage.

Xiaocai Shi1, Mary K Horn, Kris L Osterberg, John R Stofan, Jeffrey J Zachwieja, Craig A Horswill, Dennis H Passe, Robert Murray.   

Abstract

This study investigated whether different beverage carbohydrate concentration and osmolality would provoke gastrointestinal (GI) discomfort during intermittent, high-intensity exercise. Thirty-six adult and adolescent athletes were tested on separate days in a double-blind, randomized trial of 6 % and 8 % carbohydrate-electrolytes (CHO-E) beverages during four 12-min quarters (Q) of circuit training that included intermittent sprints, lateral hops, shuttle runs, and vertical jumps. GI discomfort and fatigue surveys were completed before the first Q and immediately after each Q. All ratings of GI discomfort were modest throughout the study. The cumulative index for GI discomfort, however, was greater for the 8 % CHO-E beverage than for the 6 % CHO-E beverage at Q3 and Q4 (P < 0.05). Averaging across all 4 quarters, the 8 % CHO-E treatment produced significantly higher mean ratings of stomach upset and side ache. In conclusion, higher CHO concentration and osmolality in an ingested beverage provokes stomach upset and side ache.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15657472     DOI: 10.1123/ijsnem.14.6.673

Source DB:  PubMed          Journal:  Int J Sport Nutr Exerc Metab        ISSN: 1526-484X            Impact factor:   4.599


  11 in total

1.  Beverage carbohydrate concentration influences the intermittent endurance capacity of adolescent team games players during prolonged intermittent running.

Authors:  Shaun M Phillips; Anthony P Turner; Mark F Sanderson; John Sproule
Journal:  Eur J Appl Physiol       Date:  2011-07-12       Impact factor: 3.078

Review 2.  Carbohydrate ingestion during team games exercise: current knowledge and areas for future investigation.

Authors:  Shaun M Phillips; John Sproule; Anthony P Turner
Journal:  Sports Med       Date:  2011-07-01       Impact factor: 11.136

Review 3.  Effects of acute carbohydrate supplementation on endurance performance: a meta-analysis.

Authors:  Tom J Vandenbogaerde; Will G Hopkins
Journal:  Sports Med       Date:  2011-09-01       Impact factor: 11.136

4.  Effects of oral powder electrolyte administration on packed cell volume, plasma chemistry parameters, and incidence of colic in horses participating in a 6-day 162-km trail ride.

Authors:  Wade T Walker; Robert J Callan; Ashley E Hill; Kelly B Tisher
Journal:  Can Vet J       Date:  2014-08       Impact factor: 1.008

5.  Meta-Analysis of Carbohydrate Solution Intake during Prolonged Exercise in Adults: From the Last 45+ Years' Perspective.

Authors:  Dimitrios I Bourdas; Athanasios Souglis; Emmanouil D Zacharakis; Nickos D Geladas; Antonios K Travlos
Journal:  Nutrients       Date:  2021-11-24       Impact factor: 5.717

Review 6.  Acute Effects of Carbohydrate Supplementation on Intermittent Sports Performance.

Authors:  Lindsay B Baker; Ian Rollo; Kimberly W Stein; Asker E Jeukendrup
Journal:  Nutrients       Date:  2015-07-14       Impact factor: 5.717

Review 7.  Carbohydrate-dependent, exercise-induced gastrointestinal distress.

Authors:  Erick Prado de Oliveira; Roberto C Burini
Journal:  Nutrients       Date:  2014-10-13       Impact factor: 5.717

8.  Fluid consumption, exercise, and cognitive performance.

Authors:  T P Backes; K Fitzgerald
Journal:  Biol Sport       Date:  2016-07-02       Impact factor: 2.806

9.  Musculoskeletal performance and hydration status.

Authors:  Joseph A Rothenberg; André Panagos
Journal:  Curr Rev Musculoskelet Med       Date:  2008-06

10.  Nutritional indicators for gastrointestinal symptoms in female runners: the 'Marikenloop study'.

Authors:  Dominique S M ten Haaf; Maarten P van der Worp; Hans M M Groenewoud; Susanne Leij-Halfwerk; Maria W G Nijhuis-van der Sanden; André L M Verbeek; J Bart Staal
Journal:  BMJ Open       Date:  2014-08-04       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.